Treatment Gaps: Understanding the Connection & Intervention Discrepancies
Unveiling the Complexities: Asthma’s Impact on Chronic Rhinosinusitis with Nasal Polyps
Table of Contents
A recent study examining patients within the AROMA registry sheds light on the intricate relationship between chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma, revealing significant overlaps and potential diagnostic challenges. The findings underscore the importance of a complete, multidisciplinary approach to managing these frequently enough-intertwined respiratory conditions.
Asthma’s Prevalence and Severity in CRSwNP Patients
The analysis, which included 168 patients screened for asthma, found that a substantial portion of individuals with CRSwNP also have asthma. Of the 168 patients,66 were diagnosed with asthma,representing 39.3% of the cohort. this co-occurrence is significant, as the study highlights that patients with both CRSwNP and asthma experienced a higher burden of disease.
A key finding was the impact on asthma control. Among the 66 patients diagnosed with asthma, 8 required hospitalization for severe exacerbations in the year prior to screening. These hospitalizations averaged 1.9 days, indicating a considerable impact on their quality of life and disease management.Moreover, the mean baseline 6-item Asthma Control Questionnaire (ACQ-6) score for all 168 patients was 1.4. This score suggests that a significant 40.5% of the screened population had poorly controlled asthma, defined by an ACQ-6 score of 1.5 or higher.
Symptom Overlap and Patient-Reported Outcomes
While nasal congestion scores remained consistent across both groups (mean of 1.8 for both CRSwNP-only and CRSwNP with asthma),patients with coexisting asthma reported slightly worse total symptom scores (mean TSS of 5.5 compared to 5.3) and a more pronounced loss of smell (mean LoS of 2.3 compared to 2). Despite these observed differences, researchers noted no statistically significant variations in other patient-reported outcomes between the two groups. This suggests that while subtle differences in symptom severity exist, the overall patient experience, as measured by the study’s metrics, did not reach statistical meaning, potentially due to the study’s sample size.
Medication Use and Diagnostic Considerations
Medication patterns at baseline revealed interesting trends. Patients with coexisting asthma were more likely to be using ongoing leukotriene receptor antagonists (41% vs. 16.1%) compared to those without asthma. The use of ongoing oral or systemic corticosteroids for either CRSwNP or asthma was similar between the groups (11% vs. 9.7%). Interestingly,patients with coexisting asthma used intranasal corticosteroids slightly less frequently then those without (34.3% vs. 36.6%).
These medication patterns, coupled with the symptom data, lead researchers to hypothesize that asthma may frequently be undiagnosed in patients with CRSwNP.Alternatively, a subset of patients might have indicators of lower airway dysfunction that are not yet formally recognized as an asthma diagnosis.
Limitations and Future Directions
The study authors acknowledge that the relatively small patient sample size limits the ability to draw statistically significant conclusions regarding disease severity differences between the subgroups. Additionally, crucial data on inhaled corticosteroid use and asthma-specific medication data were not collected.Future research aims to address these data gaps to provide a more comprehensive understanding of the prevalence of CRSwNP with coexisting asthma and the underlying physiological connections between these two conditions.
The Significance of FeNO Levels
The study authors concluded by highlighting the importance of elevated fractional exhaled nitric oxide (FeNO) levels observed at baseline in a portion of the AROMA population. While not present in the majority, these elevated FeNO levels are indicative of a high degree of airway inflammation and dysfunction. This finding strongly supports the necessity of a multidisciplinary approach to effectively manage chronic rhinosinusitis with nasal polyps, especially when asthma is suspected or confirmed.References
- Peters AT,Heffler E,Buchheit KM,et al.Comparing baseline characteristics of patients with chronic rhinosinusitis with nasal polyps with and without asthma in the AROMA registry. J Asthma Allergy. 2025;18:1041-1049. doi:10.2147/JAA.S519901
- What is chronic rhinosinusitis with nasal polyps (CRSwNP)? Allergy & asthma Network. Accessed July 14, 202